FDA s ectd Mandate for 2017: Latest Developments. Phillip DeNoble, PharmD, B.Sc.
|
|
- Agnes Greene
- 6 years ago
- Views:
Transcription
1 FDA s ectd Mandate for 2017: Latest Developments Phillip DeNoble, PharmD, B.Sc. 5
2 2 Nothing to disclose Disclosure
3 3 Presentation Overview Introduction/Background Good Review Practices Refuse to Receive Best Practices PDF/Scanned Documents First Hand Experiences Summary
4 4 Brief Intro/Review 5 5
5 5 Good Review Practices (GRPs) A documented best practice within CDER that discusses any aspect related to the process, format, content and/or management of a product review. GRPs are 1 : developed over time as superior practices based on experience, and provide consistency to the overall review process of new products 1 developed to improve the quality of reviews and review management. GRPs improve efficiency, clarity, and transparency of the review process and review management 1 adopted by review staff as standard processes through supervisor mentoring, implementation teams and formal training when necessary 1
6 6 Refuse to Receive (RTR) A Refuse to Receive is a GRP policy designed for ANDAs and Prior Approval Supplements ANDAs An RTR decision indicates that FDA determined that an ANDA is not substantially complete 2. The agency will evaluate each application submitted (prior to content review). The agency must deem the application as substantially complete to permit a review 2
7 7 Background on RTR Generic Drug User Fee Amendments of 2012 (GDUFA). The legislation was enacted to accomplish several tasks; one being: enhanced refusal to receive standards for ANDAs and other related submissions by the end of year 1 of the program. 3 Intended to increase agency efficacy by reducing time spent correcting improperly prepared applications 3
8 8 RTR Figures Between Fiscal Years (FY) 2013 to 2015, FDA refused to receive 379 ANDAs for reasons other than failure to pay a GDUFA fee. Of all original ANDA submissions, FDA refused to receive 4 : 14% in FY % in FY % in FY 2015
9 9 Major Deficiencies A deficiency found in 21 CFR (d)(e) or discussed in the December 2016 guidance ANDA Submissions Refuse-to-Receive Standards 6 Examples...
10 10 Major Deficiencies Examples Related to PET ANDAs 6 Form 356h* Format & Organization Sterility Assurance Data Inadequate Stability Executed Batch Record Method Validation Reports
11 11 Minor Deficiencies The agency deems the deficiency as easily remedied 6 The agency will allow the applicant with 7 calendar days to amend the ANDA 6 Only occurs if the application contains 10 or less minor deficiencies 6
12 12 What Happens After RTR? If an applicant decides to amend to application: The resultant application will be considered new and dated as such 6 The applicant will be required to pay a new ANDA Fee 6 Bear in mind PET drug exemptions
13 13 What Happens After RTR? If the applicant decided to take no action, the agency will consider the application withdrawn after one year 6 The applicant may appeal the decision 6 : Submit concerns to the listed on the RTR letter If applicant is still unsatisfied, a formal dispute resolution may be conducted in accordance with 21 CFR and the Formal Dispute Resolution: Appeals Above the Division Level guidance
14 14 Guidelines for PDFs and Scanned Documents FDA guidelines for PDFs and Scanned documents align with ICH Requirements Guidance's have been around since 2008, with revisions up to 2016
15 15 Guidelines for PDFs and Scanned Documents: Best Practices Use fonts that are known to be available on the reviewers computer 7 : Use font sizes ranging from 9 to 12 point. Times New Roman 12-point font is recommended for narrative text 7
16 16 Guidelines for PDFs and Scanned Documents: Best Practices Page Orientation: In summation; never have the reviewer flip the page 7 *** Scanning Resolution 7 : Handwritten Notes/Chromatographs: 300dpi Photos: 600dpi
17 17 Guidelines for PDFs and Scanned Documents: Best Practices All PDFs and Scanned documents should have searchable text 7 PDFs over 5 pages 7 : Indexed with a Table of Contents Hyperlinked Text
18 18 First Hand Account ANDA for 18F-FDG (post 2012 deadline) Option to submit (full ectd/hybrid/paper) Submitted September, 2015 Refuse to Receive Committee comments in October, 2015
19 19 First Hand Account Minor deficiencies found: 7 comments in total Minor changes to 356h requested (add USP or language in proposed indications) Mass and concentration of excipients listed CofAs for all components requested Minor Corrections to impurities tables include all potential impurities in the recommended tabular format with the following column headers: IUPAC Chemical Name, Code #, Chemical Structure, Degradation Impurity and Source/ Mechanism. You may refer to the OGD website for further clarification.
20 20 PDF/Scan Issues: First Hand Account Inadequate bookmarks for file entitled draft-labeling-text-pdf.pdf in section An example of an unacceptable file in your submission is the PTS printout for batch number FDG in section 3.2.P.5.4 and 3.2.R.
21 21 PDF Scan ectd Issue First Hand Account
22 22 Practical Experiences with ectd What type of model should you implement? Institution Bears Full Responsibility Hybrid (Consultant and Institution Share Responsibility) Consultant Bears Responsibility
23 23 Practical Experiences with ectd Personal Opinion: The hybrid model makes the most sense (both practically and financially) Outsource work that is overly burdensome or technical in detail Avoid software implementation costs and compliance issues Develop and prepare bulk of the application to save consultant time/fees
24 24 Miscellaneous Information Is ectd Actually Required for PET? Electronic copy of requested documents during PAI/cGMP inspections
25 25 Acknowledgments/Thanks Memorial Sloan Kettering Cancer Center Ariel Brown, Serge lyashchenko, Jason Lewis New York University CAI 2 R Dr. Yokell and the MGH PET Center
26 26 References 1. Good Review Practices (GRPs). Updated 02/13/ CFR (b)(1). Applications for FDA Approval to Market a New Drug. Revised April 1, Generic Drug User Fee Act Performance Goals and Procedures Performace Report to Congress for the Generic Drug User Fee Amendments. FY Providing Regulatory Submissions in Electronic Format Certain Human Pharmaceutical Product Applications and Related Submissions Using the ectd Specifications Guidance for Industry. Revision 4. April ANDA Submissions Refuse-to-Receive Standards Guidance for Industry. December Portable Document Formart (PDF) Specifications Guidance for Industry. September
GDUFA II: Requests for Reconsideration
GDUFA II: Requests for Reconsideration Priya Shah, Pharm.D. Immediate Office Project Manager Office of Regulatory Operations, Office of Generic Drugs Purpose To provide an overview of requests for reconsideration
More informationPOLICY AND PROCEDURES. Office of Generic Drugs and Office of Pharmaceutical Quality. Table of Contents
POLICY AND PROCEDURES Office of Generic Drugs and Office of Pharmaceutical Quality Communications with Industry with respect to pre-gdufa Year Three Abbreviated New Drug Applications Table of Contents
More informationGDUFA II IR and DR Letters Michael Folkendt, M.S.
GDUFA II IR and DR Letters Michael Folkendt, M.S. Associate Director for Regulatory Affairs Office of Program and Regulatory Operations Office of Pharmaceutical Quality, CDER, FDA 2017 AAM Fall Technical
More informationGuidance for Industry ANDA Submissions Prior Approval Supplements Under GDUFA
Guidance for Industry ANDA Submissions Prior Approval Supplements Under GDUFA DRAFT GUIDANCE This guidance document is being distributed for comment purposes only. Comments and suggestions regarding this
More informationStay Compliant! Electronic Submission of Drug Master Files (DMFs) is MANDATORY starting May 5, 2017: What You Need to Know
CDER SBIA Webinar Series Stay Compliant! Electronic Submission of Drug Master Files (DMFs) is MANDATORY starting May 5, 2017: What You Need to Know Jonathan Resnick, Project Management Officer Division
More informationGDUFA II Pre-ANDA Program Advice for Success
GDUFA II Pre-ANDA Program Advice for Success Kris Andre ADRA, Office of Research and Standards Office of Generic Drugs AAM Fall Technical Meeting November 7, 2017 GDUFA II Pre-ANDA Program: Meetings Pre-ANDA
More informationNew Requirement for Electronic Submission of DMFs
New Requirement for Electronic Submission of DMFs Ginny Hussong, Director Division of Data Management Services & Solutions Office of Business Informatics, CDER U.S. Food and Drug Administration GPhA Fall
More informationMDUFA Performance Goals and Procedures Process Improvements Pre-Submissions Submission Acceptance Criteria Interactive Review
Page 1 MDUFA Performance Goals and Procedures... 3 I. Process Improvements... 3 A. Pre-Submissions... 3 B. Submission Acceptance Criteria... 4 C. Interactive Review... 5 D. Guidance Document Development...
More informationCDER Small Business and Industry Assistance (SBIA)
CDER Small Business and Industry Assistance (SBIA) Brenda Stodart, PharmD, BCGP Director CDER Small Business and Industry Assistance (SBIA) Division of Drug Information (DDI) Center for Drug Evaluation
More informationGuidance for Industry
Guidance for Industry Self-Identification of Generic Drug Facilities, Sites, and Organizations DRAFT GUIDANCE This guidance document is being distributed for comment purposes only. Comments and suggestions
More informationInteractive Review for Medical Device Submissions: 510(k)s, Original PMAs, PMA Supplements, Original BLAs, and BLA Supplements
Guidance for Industry and FDA Staff Interactive Review for Medical Device Submissions: 510(k)s, Original PMAs, PMA Supplements, Original BLAs, and BLA Supplements Document Issued on: February 28, 2008
More informationIPEC- Americas Ongoing Projects
IPEC- Americas Ongoing s name IPEC- PDG Working group Hold technical meetings with PDG on as needed basis/meet yearly with PDG On- going monograph harmonization JECFA/Food Related Issues related to Mg
More informationAn Overview of Sterile Compounding. Marshall Moleschi, Registrar Ontario College of Pharmacists
An Overview of Sterile Compounding Marshall Moleschi, Registrar Ontario College of Pharmacists Disclosure Statement I have no real or potential conflicts, biases or relevant financial relationships to
More informationRegulatory Affairs Outsourcing
Regulatory Affairs Outsourcing INTRODUCTION The FDA Group, LLC (The FDA Group) is an organization that utilizes a proprietary talent selection process of former FDA & industry professionals, amplified
More informationReceived an RTA Deficiency List or AI Letter? Now What?
Received an RTA Deficiency List or AI Letter? Now What? Dealing with Unexpected Issues/Questions during the Submission Review Process Navigating Submission Challenges to reduce time & risk September 26,
More informationPOLICY OFFICE OF PHARMACEUTICAL QUALITY
POLICY OFFICE OF PHARMACEUTICAL QUALITY Requests for Expedited Review of New Drug Application and Biologics License Application Prior Approval Supplements Submitted for Chemistry, Manufacturing, and Controls
More informationProfiles in CSP Insourcing: Tufts Medical Center
Profiles in CSP Insourcing: Tufts Medical Center Melissa A. Ortega, Pharm.D., M.S. Director, Pediatrics and Inpatient Pharmacy Operations Tufts Medical Center Hospital Profile Tufts Medical Center (TMC)
More informationFDA Reauthorization Act of 2017 (FDARA)
FDA Reauthorization Act of 2017 (FDARA) April 4, 2018 PRESENTED BY: Jessica Ringel Counsel FDA & Life Sciences Practice Group King & Spalding LLP (202) 626-9259 jringel@kslaw.com FDA Reauthorization Act
More informationComplaint Handling and Medical Device Reporting (MDRs)
Complaint Handling and Medical Device Reporting (MDRs) FDA Small Business Regulatory Education for Industry (REdI) Bethesda, MD September 26, 2013 Andrew Xiao Consumer Safety Officer, Postmarket and Consumer
More informationFISCAL YEAR (July 1, June 30, 2015)
Office of Adult Education 1800 Century Place, N.E., Suite 300 Atlanta, Georgia 30345-4304 Beverly E. Smith, M. Ed. Assistant Commissioner INSTRUCTIONS AND GENERAL INFORMATION FOR ALL GRANTS Request for
More informationDEPARTMENT OF ENVIRONMENTAL PROTECTION Policy Office. Policy for Development and Publication of Technical Guidance
DEPARTMENT OF ENVIRONMENTAL PROTECTION Policy Office DOCUMENT NUMBER 012-0900-001 TITLE: EFFECTIVE DATE: AUTHORITY: POLICY: PURPOSE: APPLICABILITY: DISCLAIMER: Policy for Development and Publication of
More informationPractice Review Guide April 2015
Practice Review Guide April 2015 Printed: September 28, 2017 Table of Contents Section A Practice Review Policy... 1 1.0 Preamble... 1 2.0 Introduction... 2 3.0 Practice Review Committee... 4 4.0 Funding
More informationSJN DO CB Field Alert Reports. Edwin Ramos Director of Compliance Food and Drug Administration San Juan District Office
SJN DO CB Field Alert Reports Edwin Ramos Director of Compliance Food and Drug Administration San Juan District Office SJN DO Mission Assuring that safe and effective drugs are available to the public
More informationFISCAL YEAR (July 1, June 30, 2017)
Office of Adult Education 1800 Century Place, N.E., Suite 300 Atlanta, Georgia 30345-4304 Beverly E. Smith, M. Ed. Assistant Commissioner INSTRUCTIONS AND GENERAL INFORMATION FOR ALL GRANTS Request for
More informationGeneral Administration GA STANDARD OPERATING PROCEDURE FOR Document Development and Change Control
General Administration GA 104.00 STANDARD OPERATING PROCEDURE FOR Document Development and Change Control Approval: Nancy Paris, MS, FACHE President and CEO 08 March 2012 (Signature and Date) Approval:
More informationEstablishment of the FDA Office of Patient Affairs
Establishment of the FDA Office of Patient Affairs Policy Proposal: With the advent of new and innovative patient engagement programs within the Food and Drug Administration (FDA), a growing need for greater
More informationTo: Carolyn Peoples, Assistant Secretary for Fair Housing and Equal Opportunity, E. FROM: Roger E. Niesen, Regional Inspector General for Audit, 7AGA
Issue Date June 24, 2003 Audit Case Number 2003-KC-0001 To: Carolyn Peoples, Assistant Secretary for Fair Housing and Equal Opportunity, E FROM: Roger E. Niesen, Regional Inspector General for Audit, 7AGA
More informationARKANSAS COLLEGE AND CAREER COACH PROGRAM
ARKANSAS COLLEGE AND CAREER COACH PROGRAM GRANT APPLICATION GUIDELINES Dr. Charisse Childers, Director Sonja Wright-McMurray, Associate Director for CTE Special Projects Arkansas Department of Career Education
More informationGENERAL ASSEMBLY OF NORTH CAROLINA SESSION SENATE DRS15110-MGx-29G (01/14) Short Title: HealthCare Cost Reduction & Transparency.
S GENERAL ASSEMBLY OF NORTH CAROLINA SESSION 01 SENATE DRS-MGx-G (01/1) FILED SENATE Mar, 01 S.B. PRINCIPAL CLERK D Short Title: HealthCare Cost Reduction & Transparency. (Public) Sponsors: Referred to:
More informationOPDP Update on Oversight of Prescription Drug Promotion
OPDP Update on Oversight of Prescription Drug Promotion Thomas Abrams Director Office of Prescription Drug Promotion Food and Drug Administration October 20, 2016 Topics Policy and Guidance Development
More informationQ11 Development and Manufacture of Drug Substances--Questions and Answers
This document is scheduled to be published in the Federal Register on 02/26/2018 and available online at https://federalregister.gov/d/2018-03809, and on FDsys.gov 4164-01-P DEPARTMENT OF HEALTH AND HUMAN
More informationINSTRUCTIONS AND GENERAL INFORMATION Request for Application Federal Funds Adult Education Program English Literacy/Civics
Office of Adult Education 1800 Century Place, N.E., Suite 300 Atlanta, Georgia 30345-4304 Beverly E. Smith, M. Ed. Assistant Commissioner Request for Application Federal Funds Adult Education Program English
More informationLCDR Kemi Asante, PharmD, RAC Health Science Policy Analyst Office of Prescription Drug Promotion CDER FDA
Providing Regulatory Submissions in Electronic and Non-Electronic Format Promotional Labeling and Advertising Materials for Human Prescription Drugs Draft Guidance for Industry LCDR Kemi Asante, PharmD,
More informationForms Management Manual. The School District of Palm Beach County
Forms Management Manual The School District of Palm Beach County CONTENTS 1. Forms Management... 3 Program Purpose Object and Function Forms Review Committee Official Forms Index 2. Form Definitions...
More informationAt PRI, we re all about focus.
At PRI, we re all about focus. Medical Your Our niche is medical writing, including quality control and document preparation. We re focused on presenting clinical data clearly and accurately. We also concentrate
More informationCenter for Drug Evaluation and Research - Compliance Central with FDA Center Compliance Directors: Part 1
Center for Drug Evaluation and Research - Compliance Central with FDA Center Compliance Directors: Part 1 Donald D. Ashley, JD 2017 FDLI Enforcement, Litigation, and Compliance Conference: For the Drug,
More informationHIPAA in DPH. HIPAA in the Division of Public Health. February 19, February 19, 2003 Division of Public Health 1
HIPAA in the Division of Public Health February 19, 2003 February 19, 2003 Division of Public Health 1 Handouts HIPAA Definitions AG Advisory Opinion - Definition of Health Plan DPH Coverage Determination
More informationUnderstanding USP 797
Baxa Corporation Understanding USP 797 Technical Paper An Overview of USP General Chapter Pharmaceutical Compounding Sterile Preparations Mike Hurst, RPh, MBA 2004 Baxa Corporation Introduction USP
More informationPractice Review Guide
Practice Review Guide October, 2000 Table of Contents Section A - Policy 1.0 PREAMBLE... 5 2.0 INTRODUCTION... 6 3.0 PRACTICE REVIEW COMMITTEE... 8 4.0 FUNDING OF REVIEWS... 8 5.0 CHALLENGING A PRACTICE
More informationPREVENT YOUR DIETARY SUPPLEMENT LABORATORY FROM BECOMING A COMPLIANCE RISK. Marian Boardley 2013
PREVENT YOUR DIETARY SUPPLEMENT LABORATORY FROM BECOMING A COMPLIANCE RISK Marian Boardley 2013 APPLICABLE GMP S: DIETARY SUPPLEMENT LABS Subparts for laboratory operations and testing, 21 CFR 111 D Equipment
More informationMedical Device Reporting. FD&C Act CFR Direct Final Rule 2/28/05. As amended by:
Medical Device Reporting Direct Final Rule 2/28/05 FD&C Act 519 As amended by: Safe Medical Devices Act of 1990 Medical Device Amendments of 1992 FDA Modernization Act of 1997 Authority to require manufacturers,
More informationRelease Date: Tuesday, March 14, 2017 Deadline for Submissions: Friday, April 14, 2017
The Annie E. Casey Foundation s Baltimore Civic Site is seeking proposals for community-based workforce initiatives to connect unemployed and underemployed residents in East Baltimore with quality job
More informationSTATE OF FLORIDA DEPARTMENT OF HEALTH
DEPARTMENT OF HEALTH, STATE OF FLORIDA DEPARTMENT OF HEALTH PETITIONER, v. CASE NO. 2017-05245 SOUTHEAST COMPOUNDING PHARMACY, LLC, RESPON DENT. ADMINISTRATIVE COMPLAINT COMES NOW, Petitioner, Department
More information2017 GRANT APPLICATION COVER SHEET
2017 GRANT APPLICATION COVER SHEET Mission: To preserve and sustain Idaho s fishing, hunting and wildlife heritage. Please fill in this Cover Sheet completely. See Grant Application Guidelines to complete
More informationTopic: CAP s Legislative Proposal for Laboratory-Developed Tests (LDT) Date: September 14, 2015
Topic: CAP s Legislative Proposal for Laboratory-Developed Tests (LDT) Date: September 14, 2015 1. What are the CAP s views on the regulatory oversight of laboratory-developed tests (LDTs)? 2. How are
More informationEXHIBIT A SPECIAL PROVISIONS
EXHIBIT A SPECIAL PROVISIONS The following provisions supplement or modify the provisions of Items 1 through 9 of the Integrated Standard Contract, as provided herein: A-1. ENGAGEMENT, TERM AND CONTRACT
More informationSAINT AGNES MEDICAL CENTER CLINICAL RESEARCH CENTER Fresno, California. STANDARD OPERATING PROCEDURES Institutional Review Board
SAINT AGNES MEDICAL CENTER CLINICAL RESEARCH CENTER Fresno, California STANDARD OPERATING PROCEDURES Institutional Review Board Date Effective: April 26, 2001 Index No. R 1217 Date Last Revised: 0 Date
More informationREQUEST FOR PROPOSALS
Mayor s Office of Housing & Community Development (MOHCD) London N. Breed Mayor Kate Hartley Director COMMUNITY DEVELOPMENT SERVICES REQUEST FOR PROPOSALS November 1, 2018 June 30, 2019 GRANT TERM We invite
More informationICH Regulators Forum. Dr Peter Arlett EU
Dr Peter Arlett EU International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use In this presentation ICH Regulators Forum: Background ICH Regulators
More informationA guide to PDUFA V. Focus US update. Regulatory Rapporteur Vol 9, No 11, November 2012
10 A guide to PDUFA V Authors Virginia Beakes-Read JD RN, Executive Director, Global Regulatory Policy and Intelligence, Eisai, Inc; Florence Houn MD MPH FACP, Vice President, Regulatory Policy and Strategy,
More informationHospital and Other Healthcare Facilities
Hospital and Other Healthcare Facilities Council Progress Report December 2015 Judy Chong, RPh, BScPhm Manager, Hospital and Other Healthcare Facilities Agenda Background Drug Preparation Premises (DPPs)
More informationREQUEST FOR PROPOSALS PUBLIC SERVICES
Mayor s Office of Housing & Community Development (MOHCD) Edwin M. Lee Mayor Kate Hartley Acting Director REQUEST FOR PROPOSALS PUBLIC SERVICES FY 20172018 FUNDING CYCLE DATE ISSUED: Tuesday, November
More informationLEGISLATION UPDATE & STATUS OF MCC / SAHPRA and GUIDANCE TO MEET REGULATOR S EXPECTATIONS
LEGISLATION UPDATE & STATUS OF MCC / SAHPRA and GUIDANCE TO MEET REGULATOR S EXPECTATIONS Joey Gouws MCC and Cluster: Food Control, Pharmaceutical Trade and Product Regulation NATIONAL DEPARTMENT OF HEALTH
More informationINVITATION TO NEOGOTIATE ISSUED DATE ITN #
INVITATION TO NEOGOTIATE ISSUED DATE ITN # 14-0001 I. Introduction The Florida Alliance for Assistive Services and Technology, Inc. hereafter referred to as FAAST, is requesting sealed proposals from qualified
More informationFISCAL YEAR FAMILY SELF-SUFFICIENCY PROGRAM GRANT AGREEMENT (Attachment to Form HUD-1044) ARTICLE I: BASIC GRANT INFORMATION AND REQUIREMENTS
1 1 1 1 1 1 1 1 0 1 0 1 0 1 0 1 FISCAL YEAR 01 FAMILY SELF-SUFFICIENCY PROGRAM GRANT AGREEMENT (Attachment to Form HUD-) ARTICLE I: BASIC GRANT INFORMATION AND REQUIREMENTS 1. This Agreement is between
More informationFederal Funding Opportunity Page 1 of 13. Fiscal Year 2019 National Sea Grant College Program Dean John A. Knauss Marine Policy Fellowship
Federal Funding Opportunity Page 1 of 13 Fiscal Year 2019 National Sea Grant College Program Dean John A. Knauss Marine Policy Fellowship TABLE OF CONTENTS I. Funding Opportunity Description 3 A. Program
More informationUnofficial copy not valid
Page 2 (9) CONTENTS 1. PURPOSE... 3 2. DEFINITIONS... 3 3. RESPONSIBILITY... 3 4. INVESTIGATOR SELECTION... 3 4.1 Identification of Investigator s... 3 4.2 Initial Contacts... 4 4.3 Distribution of Pre-Study
More informationGUIDELINES ON PROCEDURAL ASPECTS FOR APPLICATIONS FOR MARKETING AUTHORIZATION OF MEDICINAL PRODUCTS
Doc. No. TFDA/DMC/MCER/---- TANZANIA FOOD AND DRUGS AUTHORITY GUIDELINES ON PROCEDURAL ASPECTS FOR APPLICATIONS FOR MARKETING AUTHORIZATION OF MEDICINAL PRODUCTS (Made under Section 52 (1) of the Tanzania
More informationFDA s Office of Regulatory Affairs: Violation Trends & Medical Device Update
FDA s Office of Regulatory Affairs: Violation Trends & Medical Device Update Ginger M. Sykes Supervisory Consumer Safety Officer Salt Lake City Resident Post Office of Regulatory Affairs U.S. Food and
More informationREQUEST FOR PROPOSAL CITY OF PORT ARANSAS GAS DEPARTMENT FOR NATURAL GAS SUPPLY. RFP # Gas
REQUEST FOR PROPOSAL BY CITY OF PORT ARANSAS GAS DEPARTMENT FOR NATURAL GAS SUPPLY RFP # Gas-20170501 Issue Date May 1, 2017 Questions Due Thursday, May 25, 2017 by 3pm Due Date & Time for Proposals Friday,
More informationI. Preamble: II. Parties:
I. Preamble: MEMORANDUM OF UNDERSTANDING BETWEEN THE FEDERAL COMMUNICATIONS COMMISSION AND THE FOOD AND DRUG ADMINISTRATION CENTER FOR DEVICES AND RADIOLOGICAL HEALTH The Food and Drug Administration (FDA)
More informationNotice. Update: Increased Scope of Submissions being accepted in Electronic Common Technical Document (ectd) electronic-only filing format
Notice September 30, 2011 Our file number: 11-117819-54 Update: Increased Scope of Submissions being accepted in Electronic Common Technical Document (ectd) electronic-only filing format Health Canada
More informationRegulatory Submissions Trends Survey 2002 Ellen Semple Date received (in revised form): 18th March, 2003
Ellen Semple joined CDC Solutions in July 2002 and is VP of Global Marketing. She oversees the strategic direction of CDC Solutions global marketing teams and works directly with CDC s work headquarters
More informationMEETING MINUTES. SUBJECT: FDA-GPhA Board of Directors (BOD) Quarterly Meeting
MEETING MINUTES SUBJECT: FDA-GPhA Board of Directors (BOD) Quarterly Meeting DATE: May 28, 2014 FDA ATTENDEES: Janet Woodcock - Center for Drug Evaluation and Research (CDER) Richard Moscicki - CDER Kathleen
More informationEVALUATION AND RECOMMENDATION OF PHARMACOPOEIAL TEXTS FOR USE IN THE ICH REGIONS
INTERNATIONAL CONFERENCE ON HARMONISATION OF TECHNICAL REQUIREMENTS FOR REGISTRATION OF PHARMACEUTICALS FOR HUMAN USE ICH HARMONISED TRIPARTITE GUIDELINE EVALUATION AND RECOMMENDATION OF PHARMACOPOEIAL
More informationSolutions for GCP Compliance Challenges. September 23, 2015 Northwestern University IRB Brown Bag Session
Solutions for GCP Compliance Challenges September 23, 2015 Northwestern University IRB Brown Bag Session PAMELA MASON, MPH Vice President, Mason Professional Services, LLC Adjunct Faculty, Northwestern
More informationSolutions for GCP Compliance Challenges
Solutions for GCP Compliance Challenges September 23, 2015 Northwestern University IRB Brown Bag Session PAMELA MASON, MPH Vice President, Mason Professional Services, LLC Adjunct Faculty, Northwestern
More informationRe: Transparency in Health Care Legislation Effective July 1, 2016
RICK SCOTT GOVERNOR ELIZABETH DUDEK SECRETARY May 24, 2016 Re: Transparency in Health Care Legislation Effective July 1, 2016 Governor Scott has signed into law House Bill 1175 regarding Transparency in
More informationCHAPTER SIX RESNET STANDARDS 600 ACCREDIATION STANDARD FOR SAMPLING PROVIDERS
CHAPTER SIX RESNET STANDARDS 600 ACCREDIATION STANDARD FOR SAMPLING PROVIDERS 601 GENERAL PROVISIONS 601.1 Purpose. Sampling is intended to provide certification that a group of new homes meets a particular
More informationMemorandum of Understanding. between. The General Teaching Council for Scotland. and. The Scottish Social Services Council
Memorandum of Understanding between The General Teaching Council for Scotland and The Scottish Social Services Council February 2011 Table of Contents 1 Introduction 3 2 Functions and Responsibilities
More informationFDA Perspective on the Pre- Submission Program: Updates from MDUFA IV
FDA Perspective on the Pre- Submission Program: Updates from MDUFA IV Maureen Dreher, PhD Policy Analyst Clinical Trials Program/ Office of Device Evaluation/ CDRH Agenda Pre-Submission Program background
More informationDEPARTMENT OF HUMAN SERVICES AGING AND PEOPLE WITH DISABILITIES OREGON ADMINISTRATIVE RULES CHAPTER 411 DIVISION 069 LONG TERM CARE ASSESSMENT
411-069-0000 Definitions DEPARTMENT OF HUMAN SERVICES AGING AND PEOPLE WITH DISABILITIES OREGON ADMINISTRATIVE RULES CHAPTER 411 DIVISION 069 LONG TERM CARE ASSESSMENT Unless the context indicates otherwise,
More informationOUTSOURCING SURVEY. This year we had 315 industry professionals respond
2016 Tim Wright Editor OUTSOURCING SURVEY Herein are the results of our 2016 Annual Outsourcing Survey, where we call on you, the readers, to help us benchmark the state of the pharmaceutical outsourcing
More informationPLAN OF ACTION FOR IMPLEMENTATION OF 510(K) AND SCIENCE RECOMMENDATIONS
PLAN OF ACTION FOR IMPLEMENTATION OF 510(K) AND SCIENCE RECOMMENDATIONS In August 2010, the Food and Drug Administration s Center for Devices and Radiological Health (CDRH or the Center) released for public
More information2016 Model Florida Charter School Application Frequently Asked Questions (FAQ)
2016 Model Florida Charter School Application Frequently Asked Questions (FAQ) Application Requirements 1. What are the page limit and formatting requirements for the application? Application narrative:
More informationGeneral Administration GA STANDARD OPERATING PROCEDURE FOR Sponsor Responsibility and Delegation of Responsibility
General Administration GA 102.01 STANDARD OPERATING PROCEDURE FOR Sponsor Responsibility and Delegation of Responsibility Approval: Nancy Paris, MS, FACHE President and CEO (17 July 2014) (Signature and
More informationCongress required the Secretary of DOT to prescribe regulations to establish a program requiring the certification of railroad train conductors.
FRA_RRS_ OP_2012 Congress required the Secretary of DOT to prescribe regulations to establish a program requiring the certification of railroad train conductors. This authority was delegated to the Federal
More informationWhat's New with the 356h Form? Beth Duvall Associate Director for Regulatory Affairs Office of New Drugs Center for Drug Evaluation and Research
What's New with the 356h Form? Beth Duvall Associate Director for Regulatory Affairs Office of New Drugs Center for Drug Evaluation and Research What is the Form Used For? Accompanies regulatory submissions
More informationINTERNATIONAL CONFERENCE ON HARMONISATION OF TECHNICAL REQUIREMENTS FOR REGISTRATION OF PHARMACEUTICALS FOR HUMAN USE
INTERNATIONAL CONFERENCE ON HARMONISATION OF TECHNICAL REQUIREMENTS FOR REGISTRATION OF PHARMACEUTICALS FOR HUMAN USE ICH HARMONISED TRIPARTITE GUIDELINE EVALUATION AND RECOMMENDATION OF PHARMACOPOEIAL
More informationIMPORTANT NOTICE PLEASE READ CAREFULLY SENT VIA FEDEX AND INTERNET (Receipt of this notice is presumed to be May 7, 2018 date notice ed)
Department of Health & Human Services Centers for Medicare & Medicaid Services 61 Forsyth Street, SW, Suite 4T20 Atlanta, Georgia 30303-8909 ` Refer to: 34-5529.NOTC.G.05.07.18.docx IMPORTANT NOTICE PLEASE
More informationFDA Medical Device Regulations vs. ISO 14155
Vol. 11, No. 9, September 2015 Happy Trials to You FDA Medical Device Regulations vs. ISO 14155 By Shawn Kennedy Medical device clinical trials must comply with 21 CFR Parts 11 (Electronic Records), 50
More informationSTANDARD ADMINISTRATIVE PROCEDURE
STANDARD ADMINISTRATIVE PROCEDURE 16.99.99.M0.21 Patient Request to Amend Personal Health Information Approved October 27, 2014 Next scheduled review: October 27, 2019 SAP Statement This procedure applies
More informationCenter for Devices and Radiological Health; Medical Devices and Combination Products;
This document is scheduled to be published in the Federal Register on 12/26/2017 and available online at https://federalregister.gov/d/2017-27650, and on FDsys.gov 4164-01-P DEPARTMENT OF HEALTH AND HUMAN
More informationGraduate Student Council Research Grants Program
GSC Research Grants 2016 Request for Applications (RFA) Graduate Student Council Research Grants Program An annual, competitive research grants program for graduate students at the University of Mississippi.
More informationWorking document QAS/ RESTRICTED September 2006
RESTRICTED September 2006 PREQUALIFICATION OF QUALITY CONTROL LABORATORIES Procedure for assessing the acceptability, in principle, of quality control laboratories for use by United Nations agencies The
More informationGuidance for Industry and Food and Drug Administration Staff
Requests for Feedback on Medical Device Submissions: The Pre-Submission Program and Meetings with Food and Drug Administration Staff Guidance for Industry and Food and Drug Administration Staff Document
More informationThe place of the Certification procedure in 2017 in the EU regulatory framework and beyond. Prague, 19 September 2017
The place of the Certification procedure in 2017 in the EU regulatory framework and beyond Prague, 19 September 2017 Hélène BRUGUERA Head of the Certification Department, EDQM, Council of Europe CEPs in
More informationMay 12, 2016 MEMORANDUM. Certain provisions of FSMA are already in effect, namely: Mandatory recall authority (FSMA 206).
L A W O F F I C E S 7 0 0 T H I R T E E N T H S T R E E T, N. W. S U I T E 1 2 0 0 W A S H I N G T O N, D. C. 2 0 0 0 5-5 9 2 9 ( 2 0 2 ) 7 3 7-5 6 0 0 F A C S I M I L E ( 2 0 2 ) 7 3 7-9 3 2 9 w w w.
More informationMid-term Targets of the Pharmaceuticals and Medical Devices Agency (PMDA) *(Provisional Translation)
Mid-term Targets of the Pharmaceuticals and Medical Devices Agency (PMDA) *(Provisional Translation) * This translation of the original Japanese text is for information purposes only (in the event of inconsistency,
More informationJEFFERSON COUNTY, ALABAMA. Program Year 2018 EMERGENCY SOLUTIONS GRANT APPLICATION APPLICANT:
JEFFERSON COUNTY, ALABAMA Program Year 2018 EMERGENCY SOLUTIONS GRANT APPLICATION APPLICANT: Notes: Please submit the completed application in this format with responses to sections labeled to match. Provide
More informationCommonwealth Health Research Board [CHRB] Grant Guidelines and Application Instructions for FY 2019/2020
[CHRB] Grant Guidelines and Application Instructions for FY 2019/2020 Effective July 1, 2018 for Grants to be awarded July 1, 2019 KEY DATES DUE DATES Concept Paper Submissions September 13, 2018 Full
More informationThe Nursing and Midwifery Order 2001 (SI 2002/253)
The Nursing and Midwifery Order 2001 (SI 2002/253) Unofficial consolidated text Effective from 28 July 2017 This consolidated text has been produced for internal use by the Nursing and Midwifery Council.
More informationRemediation, Resolution and Outcomes
IPA Pharmaceutical Forum 2018 22-23 February 2018 Presented by Andrei Spinei Manufacturing and Quality Compliance, European Medicines Agency An agency of the European Union Contents 1.EMA EU Network 2.Remediation
More informationProtocol for. The use of Independent Best Interests Assessors for. Deprivation of Liberty Safeguards Assessments in care homes and hospitals
Protocol for The use of Independent Best Interests Assessors for Deprivation of Liberty Safeguards Assessments in care homes and hospitals Report Author: Lorraine Currie Revised April 2013 Review Date:
More informationCounty of Santa Clara, California Social Services Agency Request for Proposals For Supportive and Therapeutic Options Program (STOP)
County of Santa Clara, California Social Services Agency Request for Proposals For Supportive and Therapeutic Options Program (STOP) Social Service Agency 333 West Julian Street San Jose, CA 95110-2335
More informationANNOUNCEMENT OF FEDERAL FUNDING OPPORTUNITY EXECUTIVE SUMMARY
Page 1 of 11 ANNOUNCEMENT OF FEDERAL FUNDING OPPORTUNITY EXECUTIVE SUMMARY Federal Agency Name(s): Oceanic and Atmospheric Research (OAR), National Oceanic and Atmospheric Administration (NOAA), Department
More informationBIMO Program Update an operational perspective
BIMO Program Update an operational perspective Clinical Trials Summit San Juan, Puerto Rico May 9, 2018 Anne E. Johnson Program Division Director FDA/ORA/OBIMO Division I (East) 1 Objectives Program Alignment
More informationMedical Devices and Device-Led Combination Products; Voluntary Malfunction Summary
This document is scheduled to be published in the Federal Register on 08/17/2018 and available online at https://federalregister.gov/d/2018-17770, and on govinfo.gov 4164-01-P DEPARTMENT OF HEALTH AND
More informationInvestigator Roles and Responsibilities in Clinical Device Trials
Investigator Roles and Responsibilities in Clinical Device Trials A Total Product Lifecycle Approach to Medical Device Development: Responsibilities and Opportunities The Stanford Center for Clinical and
More informationOMeGA Medical Grants Association RESIDENCY/CORE COMPETENCY INNOVATION GRANT RECIPIENT AGREEMENT. Order number* Program applicant name*
OMeGA Medical Grants Association 2015-2016 RESIDENCY/CORE COMPETENCY INNOVATION GRANT RECIPIENT AGREEMENT Order number* Program applicant name* This Grant Recipient Agreement is between OMeGA Medical Grants
More information